Compare VRCA & NBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | NBRG |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 74.5M |
| IPO Year | 2018 | 2026 |
| Metric | VRCA | NBRG |
|---|---|---|
| Price | $6.30 | $9.90 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 70.2K | 42.3K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,577,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $94.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 370.22 | N/A |
| 52 Week Low | $0.39 | $9.59 |
| 52 Week High | $9.82 | $9.91 |
| Indicator | VRCA | NBRG |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 62.50 |
| Support Level | $5.16 | N/A |
| Resistance Level | $7.35 | N/A |
| Average True Range (ATR) | 0.42 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 46.91 | 96.87 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Newbridge Acquisition Ltd is a blank check company.